09/21/2818 10:18 From: Woodson C. Merrell M Uebfax Page: 3/13
09/21/2818 10:18 From: Woodson C. Merrell M Uebfax Page: 3/13
sr.LabCorp Pasecsuditimmnislo
D0emna79” Patient Report
Patient ID: ConcrolMJSBW0092 SPninsen ID: 257-410-2371.0
Date collected: 09!!4.2018 255 Local
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB BUN
Creatinine
eGFR If NonAfricn Am
eGFR If Africn Am
BUN/Creatinine Ratio
Sodium
Potassium 22
0.96
83
95
23
138
4.2 mg/dL
mg/dL
mL/min/1.73
mL/min/1.73 8 - 27
0.76 - 1.27 01
>59
>59
10 - 24
mMO1/L 134 - 144 01
anol/L 3.5 - 5.2 01 Sample is lipemic. This may cause spurious increases in IBM, DBili, AST, ALT, and UIBC (if ordered) . Clinical correlation indicated Specimen received hemolyzed. Clinical correlation indicated.
Chloride 102 mmol/L 96
Carbon Dioxide, Total 20 mmol/L 20
Calcium 9.4 mg/dL 8.6 -Protein, Total 6.7 g/dL 6.0 -
Albumin ♦.3 g/dL 3.6 -
Globulin, Total 2.4 g/dL 1.5
A/G Ratio 1.8 1.2
Bilirubin, Total 0.3 mg/dL 0.0
Alkaline Phosphatase 71 IU/L 39
AST (SOOT) 26 IU/L 0 -The specimen was lipemic. The lipemia was cleared by ultracentrifugation before testing. However HDL, direct LDL, cholesterol and triglyceride (if ordered) were performed prior to ultracentrifugation.
ALT (SGPT) •
urinalysis, Routine
Urinalysis Gross Exam
Specific Gravity
pH
Urine-Color
Appearance
WBC Esterase
Protein
Glucose
Ketones
Occult Blood
Bilirubin
Urobilinogen,Semi-Qn
Nitrite, Urine
Microscopic Examination
Microscopic follows
PE+Interp(Rfx IFE),8 37 IU/L
1.027
5.5
Yellow
Clear
Negative
Negative
Negative
Negative
Negative
Negative
0.2
Negative
if indicated. 01
106 01
29 01
10.2 01
8.5 01
4.8 01
4.5
2.2
1.2 01
117 01
40 01
0 - 44 01
01
1.005 - 1.030 01
5.0 - 7.5 01
Yellow 01
Clear 01
Negative 01
Negative/Trace 01
Negative 01
Negative 01
Negative 01
Negative 01
EU/dL 0.2 - 1.0 01
Negative 01
01
iniswect09/2011SOMET RNA/REPORT
ibis&mmwincomeftplimerwicordositaftwahhfomwtonormaildtwommarWittleallow.
II you hes receNed tin claciarneet in snot passe cal hipid6
03954MSUbentogespora8m0MmkAWAM9s
MftraftsemWAflerwW/RworOomiomnA
EFTA00314054